Home > Healthcare > Medical Devices > Surgical Devices > Heart-lung Machine Market

Heart-lung Machine Market Trends

  • Report ID: GMI6060
  • Published Date: Jun 2023
  • Report Format: PDF

Heart-lung Machine Market Trends

Increasing prevalence of cardiovascular diseases is anticipated to increase the adoption of heart-lung machine globally. Cardiovascular diseases, such as coronary artery disease, heart failure, and valvular heart disease, are becoming increasingly common globally. The aging population, sedentary lifestyles, unhealthy diets, and other risk factors contribute to the rising incidence of these diseases. For instance, according to the NCBI data, in 2021, around 400,000 CABG surgeries are performed each year in America and is expected to increase in the near future. Heart-lung machines are essential for performing open-heart surgeries, including coronary artery bypass grafting (CABG), valve repair/replacement, and congenital heart defect corrections.
 

Advancements in surgical techniques and technologies have expanded the scope of cardiac surgeries, making them safer and more feasible for a broader range of patients. These advancements include minimally invasive procedures, robotic-assisted surgeries, and transcatheter interventions. The prevalence of congenital heart diseases in infants and children necessitates the use of heart-lung machines to provide temporary support to the heart and lungs during complex procedures. Heart-lung machines have proven effective and efficient in several cardiovascular surgeries, thereby augmenting the product demand.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

The market size of heart-lung machine was reached USD 343 million in 2022 and will reach over USD 520 million by 2032, due to increasing prevalence of cardiovascular disorders, coupled with rising number of transplant surgeries.

The single roller pump held a dominant market share of around 60% in 2022, owing to several clinical benefits offered by single roller pump heart-lung machine such as propelling blood through the circuit, eliminating the need for complex mechanisms.

North America market will reach around USD 141 million by 2032, attributable to the presence of key players in the region, an increasing prevalence of cardiovascular diseases, and rising awareness regarding the benefits of heart-lung machines.

Braile Biomedica, Edwards Lifesciences Corp., ELITE LIFECARE, Eurosets Srl, Getinge AB, Heart Care India Co., Hemovent GmbH, Jarvik Heart Inc., Koninklijke Philips NV, LivaNova Plc, and Medtronic Plc.

Heart-lung Machine Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 16
  • Tables & Figures: 363
  • Countries covered: 30
  • Pages: 180
 Download Free Sample